about
Risks and benefits of citrate anticoagulation for continuous renal replacement therapyExtracorporeal blood purification for sepsisPreoperative red cell distribution width: Not a useful prognostic indicator for 30-day mortality in patients who undergo major- or ultra-major noncardiac surgery.Timing for initiation of continuous renal replacement therapy in patients with septic shock and acute kidney injury.Recent knowledge on the pathophysiology of septic acute kidney injury: A narrative review.Clinical Outcomes of Extended Versus Intermittent Infusion of Piperacillin/Tazobactam in Critically Ill Patients: A Prospective Clinical Trial.A case of severe empyema with acute respiratory distress syndrome caused by Slackia exigua requiring veno-venous extracorporeal membrane oxygenation.Clinical predictors and outcomes of Klebsiella pneumoniae bacteraemia in a regional hospital in Hong Kong.Outcome of elderly patients who receive intensive care at a regional hospital in Hong Kong.Septic acute kidney injury in critically ill patients - a single-center study on its incidence, clinical characteristics, and outcome predictors.Alteco endotoxin hemoadsorption in Gram-negative septic shock patientsTriage decisions and outcomes for patients with Triage Priority 3 on the Society of Critical Care Medicine scale.Timing for initiation of continuous renal replacement therapy in patients with septic shock and acute kidney injury.Treatment of Acute Kidney Injury Complicating Septic Shock with EMiC2 High-cutoff Hemofilter: Case Series.Impact of renal replacement therapy on survival in patients with KDIGO Stage 3 acute kidney injury: A propensity score matched analysis.A Case of Lemierre's Syndrome in Intensive Care Unit.Alteco endotoxin hemoadsorption in Gram-negative septic shock patients.Emergence of carbapenem-resistant hypervirulent Klebsiella pneumoniaeCast nephropathy with acute renal failure treated with high cut-off haemodialysis in a patient with multiple myelomaRegional citrate anticoagulation in predilution continuous venovenous hemofiltration using prismocitrate 10/2 solutionStar fruit intoxication successfully treated by charcoal haemoperfusion and intensive haemofiltrationInteraction between fluid balance and disease severity on patient outcome in the critically illClostridium perfringens liver abscess with massive haemolysisPredictive value of plasma neutrophil gelatinase-associated lipocalin for acute kidney injury in intensive care unit patients after major non-cardiac surgeryTiming for initiation of continuous renal replacement therapy in patients with septic shock and acute kidney injuryCharacteristics of patients readmitted to intensive care unit: a nested case-control studyThe use of regional citrate anticoagulation continuous venovenous hemofiltration in extracorporeal membrane oxygenationThe aquarium in the right heartImpact of Hyperoxia and Hypocapnia on Neurological Outcomes in Patients with Aneurysmal Subarachnoid Hemorrhage: A Retrospective StudyImpact of Dysnatremia and Dyskalemia on Prognosis in Patients with Aneurysmal Subarachnoid Hemorrhage: A Retrospective StudyESICM LIVES 2016: part two: Milan, Italy. 1–5 October 2016Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
P50
Q26823712-6616C9CB-EAF7-47B5-8F15-0E2719E61BD9Q28067163-F000B43C-96B9-46DE-88AF-2BA3A66243FDQ37484500-9A706B44-9C58-425C-85DE-C80B024E45E6Q38111847-6D215845-6B68-4746-A2B1-D5D95713D6A5Q38609403-C04E93AA-6C9C-4E9E-B0A4-D21A7CA292A7Q40078698-74B3C3B7-E319-4467-A93D-3A601EDEEEEBQ40150698-9CF0D925-9A8A-4DE7-A127-B54A50AC838DQ40177367-88D3C514-5AB7-4ED1-9C60-D92C708573C1Q40489687-448CE391-0A96-4554-8AE2-44B3D6D2375AQ40753600-8512BC04-9287-4902-AD77-ADCF49ABE4C5Q41946739-C2772382-E1C1-44E0-BEAC-404923636688Q43948219-57FE1039-336E-4BAF-BA35-C7AC3270003EQ45933137-3FB22474-51E9-4495-8B36-CA4D399B4EC8Q47119189-CCDF9034-6ECB-436A-B259-6F1657CCA9D1Q47253539-D36C625F-C9C1-4D41-952B-DC9D611BFFD3Q55262773-A2B89B6E-BB64-4186-96EC-AE0423BE2A52Q55446417-2E5EB967-0365-4C52-B1F3-40B902445F62Q59698214-083C463D-687F-4297-80FF-9694DE4192DAQ82767593-714296B3-EC83-4090-A3CA-7A9805C19850Q83251521-704D5218-C86A-4377-A478-2D7E28D3DC9EQ83603260-82159668-94F8-4248-8219-1478F559598FQ83936569-D32F1BBD-7C75-4D83-BD99-BC357390D7D8Q84652664-B2E678E2-BEBC-4BA0-98FD-B4061262DCC4Q86565627-1D38476F-C318-4003-8F74-C03407D2E052Q86938027-EED06E65-44F2-4747-A847-CC8DAD90D070Q87300432-75FD1417-00D7-437F-ADF2-10501D34C2D5Q87671629-D01BAE09-0664-4EE3-92C2-157E0289191EQ90766939-7AEF4061-BBF3-4391-B32F-361148CBD6BFQ92310655-22040ECC-EA83-468C-B1F1-2106841F7DF2Q92979767-5BF7937A-BFA1-43E4-8887-68884AB7B353Q93856524-658DF748-AFAF-4E7A-A7CA-8A75BCB4D5D0Q94657383-EFA562D2-F7F1-46A1-BA6A-98C1F8EC5FC1
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
H P Shum
@en
H P Shum
@nl
type
label
H P Shum
@en
H P Shum
@nl
prefLabel
H P Shum
@en
H P Shum
@nl
P31
P496
0000-0001-7002-3548